Aptevo Therapeutics Inc.
APVO· Nasdaq
APVOAptevo Therapeutics Inc.
Filed May 12, 2017 · 10-Q · 42 days after period end · 0001564590-17-010737
| Metric | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|
| Revenue | $2.14M | $8.07M | $11.66M |
| Net Income | -$9.95M | -$12.89M | -$11.02M |
| EPS Diluted | -$0.48 | -$0.64 | -$0.54 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 12, 2017 · 42 d after period end
